DNA Link Inc
KOSDAQ:127120
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DNA Link Inc
Income from Continuing Operations
DNA Link Inc
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DNA Link Inc
KOSDAQ:127120
|
Income from Continuing Operations
-₩16.4B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
|
Celltrion Inc
KRX:068270
|
Income from Continuing Operations
₩1T
|
CAGR 3-Years
25%
|
CAGR 5-Years
14%
|
CAGR 10-Years
22%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Income from Continuing Operations
-₩15.7B
|
CAGR 3-Years
18%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Income from Continuing Operations
-₩32.6B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Income from Continuing Operations
₩145.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
61%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Income from Continuing Operations
-₩37.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
DNA Link Inc
Glance View
DNA Link, Inc. provides genomic analysis services. The company is headquartered in Seoul, Seoul. The company went IPO on 2011-12-26. The firm provides genome biomarkers excavation products through integrated genomic analysis and integrated clinical information analysis including high-quality data products according to genomic analysis, interpretation of analysis results, and technologies of molecular diagnostic kit production under the brand name of enhanced genome integration system (EGIS). The firm also provides personal genome analysis service products under the brand name of deoxyribonucleic acid personalized services (DNAGPS).
See Also
What is DNA Link Inc's Income from Continuing Operations?
Income from Continuing Operations
-16.4B
KRW
Based on the financial report for Dec 31, 2025, DNA Link Inc's Income from Continuing Operations amounts to -16.4B KRW.
What is DNA Link Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-6%
Over the last year, the Income from Continuing Operations growth was -52%. The average annual Income from Continuing Operations growth rates for DNA Link Inc have been -27% over the past three years , -4% over the past five years , and -6% over the past ten years .
